These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
517 related articles for article (PubMed ID: 24278780)
1. Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome. Barton RC Scientifica (Cairo); 2013; 2013():459405. PubMed ID: 24278780 [TBL] [Abstract][Full Text] [Related]
2. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model]. Aydoğan S; Kuştimur S; Kalkancı A Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994 [TBL] [Abstract][Full Text] [Related]
4. The current management landscape: aspergillosis. Maertens JA; Blennow O; Duarte RF; Muñoz P J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii23-ii29. PubMed ID: 27880666 [TBL] [Abstract][Full Text] [Related]
5. Defining the diagnosis of invasive aspergillosis. Chamilos G; Kontoyiannis DP Med Mycol; 2006 Sep; 44(Supplement_1):S163-S173. PubMed ID: 30408899 [TBL] [Abstract][Full Text] [Related]
6. Study on invasive aspergillosis using galactomannan enzyme immunoassay and determining antifungal drug susceptibility among hospitalized patients with hematologic malignancies or candidates for organ transplantation. Ardi P; Daie-Ghazvini R; Hashemi SJ; Salehi MR; Bakhshi H; Rafat Z; Zareei M; Getso M; Basiri S; Sarwestani HK; Boroujeini ZB; Ahmadikia K Microb Pathog; 2020 Oct; 147():104382. PubMed ID: 32663605 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic potential of nested PCR, galactomannan EIA, and beta-D-glucan for invasive aspergillosis in pediatric patients. Badiee P; Alborzi A; Karimi M; Pourabbas B; Haddadi P; Mardaneh J; Moieni M J Infect Dev Ctries; 2012 Apr; 6(4):352-7. PubMed ID: 22505446 [TBL] [Abstract][Full Text] [Related]
8. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people. Cruciani M; Mengoli C; Loeffler J; Donnelly P; Barnes R; Jones BL; Klingspor L; Morton O; Maertens J Cochrane Database Syst Rev; 2015 Oct; (10):CD009551. PubMed ID: 26424726 [TBL] [Abstract][Full Text] [Related]
17. Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan. Mikulska M; Furfaro E; De Carolis E; Drago E; Pulzato I; Borghesi ML; Zappulo E; Raiola AM; Grazia CD; Del Bono V; Cittadini G; Angelucci E; Sanguinetti M; Viscoli C Med Mycol; 2019 Nov; 57(8):987-996. PubMed ID: 30753590 [TBL] [Abstract][Full Text] [Related]
18. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis. Eigl S; Hoenigl M; Spiess B; Heldt S; Prattes J; Neumeister P; Wolfler A; Rabensteiner J; Prueller F; Krause R; Reinwald M; Flick H; Buchheidt D; Boch T Med Mycol; 2017 Jul; 55(5):528-534. PubMed ID: 27744310 [TBL] [Abstract][Full Text] [Related]
19. Prospective Evaluation of the Turbidimetric β-D-Glucan Assay and 2 Lateral Flow Assays on Serum in Invasive Aspergillosis. Mercier T; Guldentops E; Lagrou K; Maertens J Clin Infect Dis; 2021 May; 72(9):1577-1584. PubMed ID: 32188971 [TBL] [Abstract][Full Text] [Related]
20. Galactomannan and 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Aspergillosis. Lamoth F J Fungi (Basel); 2016 Jul; 2(3):. PubMed ID: 29376937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]